nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—polycystic ovary syndrome	0.528	0.596	CbGaD
Fludrocortisone—NR3C1—polycystic ovary syndrome	0.358	0.404	CbGaD
Fludrocortisone—NR3C1—urine—polycystic ovary syndrome	0.00503	0.109	CbGeAlD
Fludrocortisone—NR3C2—Preimplantation Embryo—MYBL1—polycystic ovary syndrome	0.0034	0.0592	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ACE—polycystic ovary syndrome	0.0029	0.0505	CbGpPWpGaD
Fludrocortisone—NR3C2—adrenal cortex—polycystic ovary syndrome	0.00248	0.0536	CbGeAlD
Fludrocortisone—NR3C2—endometrium—polycystic ovary syndrome	0.00222	0.0479	CbGeAlD
Fludrocortisone—AR—Nongenotropic Androgen signaling—SHBG—polycystic ovary syndrome	0.00222	0.0386	CbGpPWpGaD
Fludrocortisone—NR3C2—uterus—polycystic ovary syndrome	0.00204	0.0441	CbGeAlD
Fludrocortisone—NR3C2—pituitary gland—polycystic ovary syndrome	0.00201	0.0433	CbGeAlD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—TMF1—polycystic ovary syndrome	0.002	0.0348	CbGpPWpGaD
Fludrocortisone—NR3C2—adipose tissue—polycystic ovary syndrome	0.002	0.0431	CbGeAlD
Fludrocortisone—AR—adrenal cortex—polycystic ovary syndrome	0.00184	0.0397	CbGeAlD
Fludrocortisone—NR3C2—adrenal gland—polycystic ovary syndrome	0.00179	0.0387	CbGeAlD
Fludrocortisone—NR3C2—female gonad—polycystic ovary syndrome	0.00167	0.0361	CbGeAlD
Fludrocortisone—NR3C2—vagina—polycystic ovary syndrome	0.00166	0.0359	CbGeAlD
Fludrocortisone—AR—endometrium—polycystic ovary syndrome	0.00164	0.0354	CbGeAlD
Fludrocortisone—NR3C1—embryo—polycystic ovary syndrome	0.00163	0.0351	CbGeAlD
Fludrocortisone—NR3C2—endocrine gland—polycystic ovary syndrome	0.00155	0.0335	CbGeAlD
Fludrocortisone—AR—uterus—polycystic ovary syndrome	0.00151	0.0327	CbGeAlD
Fludrocortisone—AR—pituitary gland—polycystic ovary syndrome	0.00149	0.0321	CbGeAlD
Fludrocortisone—AR—adipose tissue—polycystic ovary syndrome	0.00148	0.0319	CbGeAlD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.00134	0.0233	CbGpPWpGaD
Fludrocortisone—NR3C1—adrenal cortex—polycystic ovary syndrome	0.00133	0.0287	CbGeAlD
Fludrocortisone—AR—adrenal gland—polycystic ovary syndrome	0.00133	0.0286	CbGeAlD
Fludrocortisone—AR—Nongenotropic Androgen signaling—GNRH1—polycystic ovary syndrome	0.00127	0.0222	CbGpPWpGaD
Fludrocortisone—AR—female gonad—polycystic ovary syndrome	0.00124	0.0267	CbGeAlD
Fludrocortisone—AR—vagina—polycystic ovary syndrome	0.00123	0.0266	CbGeAlD
Fludrocortisone—NR3C1—endometrium—polycystic ovary syndrome	0.00119	0.0257	CbGeAlD
Fludrocortisone—AR—endocrine gland—polycystic ovary syndrome	0.00115	0.0248	CbGeAlD
Fludrocortisone—NR3C1—uterus—polycystic ovary syndrome	0.0011	0.0237	CbGeAlD
Fludrocortisone—NR3C1—pituitary gland—polycystic ovary syndrome	0.00108	0.0232	CbGeAlD
Fludrocortisone—NR3C1—adipose tissue—polycystic ovary syndrome	0.00107	0.0231	CbGeAlD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.00104	0.0181	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.00101	0.0176	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.00101	0.0176	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—INSR—polycystic ovary syndrome	0.000997	0.0174	CbGpPWpGaD
Fludrocortisone—NR3C1—adrenal gland—polycystic ovary syndrome	0.000961	0.0207	CbGeAlD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—polycystic ovary syndrome	0.000921	0.016	CbGpPWpGaD
Fludrocortisone—NR3C1—female gonad—polycystic ovary syndrome	0.000896	0.0193	CbGeAlD
Fludrocortisone—NR3C1—vagina—polycystic ovary syndrome	0.000891	0.0192	CbGeAlD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.000842	0.0147	CbGpPWpGaD
Fludrocortisone—NR3C1—endocrine gland—polycystic ovary syndrome	0.000834	0.018	CbGeAlD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000831	0.0145	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000786	0.0137	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—polycystic ovary syndrome	0.000785	0.0137	CbGpPWpGaD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—polycystic ovary syndrome	0.000741	0.0129	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CAMK2D—polycystic ovary syndrome	0.00068	0.0118	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—polycystic ovary syndrome	0.00067	0.0117	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.000668	0.0116	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000652	0.0113	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LIFR—polycystic ovary syndrome	0.000628	0.0109	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—HSD3B2—polycystic ovary syndrome	0.000622	0.063	CrCbGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000621	0.0108	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000596	0.0104	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.00059	0.0103	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000554	0.00964	CbGpPWpGaD
Fludrocortisone—Dydrogesterone—PGR—polycystic ovary syndrome	0.000547	0.0554	CrCbGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.00053	0.00923	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—polycystic ovary syndrome	0.000528	0.00918	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—LEP—polycystic ovary syndrome	0.000516	0.00899	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—RETN—polycystic ovary syndrome	0.000512	0.00891	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LIF—polycystic ovary syndrome	0.000512	0.00891	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.000494	0.0086	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—NAMPT—polycystic ovary syndrome	0.000488	0.00849	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ZNF205—polycystic ovary syndrome	0.000487	0.00847	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ZNF430—polycystic ovary syndrome	0.000487	0.00847	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000471	0.0082	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000469	0.00817	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000469	0.00817	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—AR—polycystic ovary syndrome	0.000464	0.00807	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—polycystic ovary syndrome	0.000461	0.00802	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—NCOR1—polycystic ovary syndrome	0.000451	0.00784	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—polycystic ovary syndrome	0.00045	0.00783	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000448	0.0078	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—polycystic ovary syndrome	0.000414	0.00721	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ADARB1—polycystic ovary syndrome	0.000414	0.0072	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.000391	0.0068	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000383	0.00666	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—NR3C1—polycystic ovary syndrome	0.000379	0.00659	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—polycystic ovary syndrome	0.000375	0.00652	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000366	0.00638	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000356	0.0062	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000356	0.0062	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—AR—polycystic ovary syndrome	0.000355	0.00618	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00035	0.00608	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—AKR1C3—polycystic ovary syndrome	0.000345	0.0349	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—LSM5—polycystic ovary syndrome	0.000337	0.00587	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—INS—polycystic ovary syndrome	0.000334	0.00581	CbGpPWpGaD
Fludrocortisone—Megestrol acetate—PGR—polycystic ovary syndrome	0.000329	0.0333	CrCbGaD
Fludrocortisone—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.000325	0.0329	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.00032	0.00556	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.000316	0.00551	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SAP30L—polycystic ovary syndrome	0.000314	0.00546	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000312	0.00542	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000303	0.00527	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—NCOR1—polycystic ovary syndrome	0.000302	0.00525	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000292	0.00508	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000291	0.00506	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—NCOR1—polycystic ovary syndrome	0.00027	0.00471	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.00027	0.0047	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—polycystic ovary syndrome	0.000267	0.00465	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—TEAD2—polycystic ovary syndrome	0.000267	0.00464	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000265	0.00461	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000265	0.00461	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—PRL—polycystic ovary syndrome	0.000261	0.00455	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000257	0.00447	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000253	0.00441	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.000253	0.0044	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—NAMPT—polycystic ovary syndrome	0.000245	0.00427	CbGpPWpGaD
Fludrocortisone—Diflorasone—NR3C1—polycystic ovary syndrome	0.000233	0.0236	CrCbGaD
Fludrocortisone—Desonide—NR3C1—polycystic ovary syndrome	0.000233	0.0236	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—LMNA—polycystic ovary syndrome	0.000233	0.00405	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000231	0.00402	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000231	0.00402	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.00023	0.004	CbGpPWpGaD
Fludrocortisone—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000227	0.023	CrCbGaD
Fludrocortisone—AR—Gene Expression—ZNF430—polycystic ovary syndrome	0.000226	0.00393	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ZNF205—polycystic ovary syndrome	0.000226	0.00393	CbGpPWpGaD
Fludrocortisone—Loteprednol—NR3C1—polycystic ovary syndrome	0.000225	0.0228	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000222	0.00386	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000221	0.00385	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000216	0.00376	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—BAX—polycystic ovary syndrome	0.000214	0.00372	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000213	0.00371	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—SHBG—polycystic ovary syndrome	0.000209	0.0211	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000208	0.00363	CbGpPWpGaD
Fludrocortisone—Spironolactone—PGR—polycystic ovary syndrome	0.000204	0.0207	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000201	0.00349	CbGpPWpGaD
Fludrocortisone—Flurandrenolide—NR3C1—polycystic ovary syndrome	0.000199	0.0202	CrCbGaD
Fludrocortisone—Testosterone Propionate—AR—polycystic ovary syndrome	0.000197	0.02	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000195	0.00339	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—SERPINE1—polycystic ovary syndrome	0.000195	0.00339	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	0.000193	0.00335	CbGpPWpGaD
Fludrocortisone—Hydrocortamate—NR3C1—polycystic ovary syndrome	0.000193	0.0195	CrCbGaD
Fludrocortisone—AR—Gene Expression—ADARB1—polycystic ovary syndrome	0.000192	0.00334	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—PGR—polycystic ovary syndrome	0.000192	0.0194	CrCbGaD
Fludrocortisone—Spironolactone—SHBG—polycystic ovary syndrome	0.000191	0.0194	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—RPL37A—polycystic ovary syndrome	0.00019	0.00331	CbGpPWpGaD
Fludrocortisone—Cortisone acetate—NR3C1—polycystic ovary syndrome	0.00019	0.0192	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.00019	0.0033	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000188	0.00328	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—AR—polycystic ovary syndrome	0.000183	0.0185	CrCbGaD
Fludrocortisone—Megestrol acetate—NR3C1—polycystic ovary syndrome	0.000183	0.0185	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.00018	0.00313	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—SHBG—polycystic ovary syndrome	0.000179	0.0181	CrCbGaD
Fludrocortisone—Amcinonide—NR3C1—polycystic ovary syndrome	0.000179	0.0181	CrCbGaD
Fludrocortisone—Betamethasone—PGR—polycystic ovary syndrome	0.000174	0.0176	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000173	0.003	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000171	0.00298	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000171	0.00298	CbGpPWpGaD
Fludrocortisone—Mometasone—NR3C1—polycystic ovary syndrome	0.00017	0.0173	CrCbGaD
Fludrocortisone—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000169	0.0171	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000168	0.00293	CbGpPWpGaD
Fludrocortisone—Spironolactone—AR—polycystic ovary syndrome	0.000168	0.017	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00016	0.00278	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000157	0.00274	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—AR—polycystic ovary syndrome	0.000157	0.0159	CrCbGaD
Fludrocortisone—AR—Gene Expression—LSM5—polycystic ovary syndrome	0.000157	0.00273	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	0.000155	0.00269	CbGpPWpGaD
Fludrocortisone—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.000154	0.0156	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	0.000152	0.00264	CbGpPWpGaD
Fludrocortisone—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.00015	0.0152	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00015	0.00261	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP17A1—polycystic ovary syndrome	0.000149	0.0151	CrCbGaD
Fludrocortisone—Methyltestosterone—AR—polycystic ovary syndrome	0.000148	0.015	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000146	0.00254	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SAP30L—polycystic ovary syndrome	0.000146	0.00253	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000145	0.00253	CbGpPWpGaD
Fludrocortisone—Fluorometholone—NR3C1—polycystic ovary syndrome	0.000145	0.0147	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000143	0.00249	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000143	0.00249	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.00014	0.0142	CrCbGaD
Fludrocortisone—Testosterone—CYP11A1—polycystic ovary syndrome	0.000139	0.0141	CrCbGaD
Fludrocortisone—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.000136	0.0138	CrCbGaD
Fludrocortisone—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.000136	0.0138	CrCbGaD
Fludrocortisone—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000134	0.0136	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.00013	0.00226	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—YAP1—polycystic ovary syndrome	0.000127	0.00222	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	0.000127	0.00222	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000127	0.0129	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	0.000125	0.00217	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—NR3C1—polycystic ovary syndrome	0.000124	0.0126	CrCbGaD
Fludrocortisone—AR—Gene Expression—TEAD2—polycystic ovary syndrome	0.000124	0.00215	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—CYP19A1—polycystic ovary syndrome	0.000124	0.0125	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000123	0.00214	CbGpPWpGaD
Fludrocortisone—Betamethasone—CYP19A1—polycystic ovary syndrome	0.000119	0.0121	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	0.000119	0.00207	CbGpPWpGaD
Fludrocortisone—Triamcinolone—NR3C1—polycystic ovary syndrome	0.000118	0.012	CrCbGaD
Fludrocortisone—Spironolactone—NR3C1—polycystic ovary syndrome	0.000114	0.0115	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000113	0.00196	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000112	0.00196	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PGR—polycystic ovary syndrome	0.000111	0.00194	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	0.000111	0.00194	CbGpPWpGaD
Fludrocortisone—Progesterone—PGR—polycystic ovary syndrome	0.000111	0.0112	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	0.00011	0.00192	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	0.000109	0.00189	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000107	0.00187	CbGpPWpGaD
Fludrocortisone—Prednisone—NR3C1—polycystic ovary syndrome	0.000107	0.0108	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	0.000107	0.00185	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—NR3C1—polycystic ovary syndrome	0.000106	0.0108	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	0.000105	0.00183	CbGpPWpGaD
Fludrocortisone—Progesterone—SHBG—polycystic ovary syndrome	0.000103	0.0105	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	0.000103	0.00179	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000101	0.00177	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PGR—polycystic ovary syndrome	0.000101	0.0102	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	9.98e-05	0.00174	CbGpPWpGaD
Fludrocortisone—Prednisolone—NR3C1—polycystic ovary syndrome	9.87e-05	0.01	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	9.78e-05	0.0017	CbGpPWpGaD
Fludrocortisone—Testosterone—SHBG—polycystic ovary syndrome	9.78e-05	0.0099	CrCbGaD
Fludrocortisone—Betamethasone—NR3C1—polycystic ovary syndrome	9.67e-05	0.00979	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	9.39e-05	0.00163	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	9.32e-05	0.00162	CbGpPWpGaD
Fludrocortisone—Progesterone—AR—polycystic ovary syndrome	9.07e-05	0.00918	CrCbGaD
Fludrocortisone—AR—Gene Expression—RPL37A—polycystic ovary syndrome	8.82e-05	0.00153	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	8.71e-05	0.00152	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AR—polycystic ovary syndrome	8.66e-05	0.00151	CbGpPWpGaD
Fludrocortisone—Testosterone—AR—polycystic ovary syndrome	8.57e-05	0.00868	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	8.14e-05	0.00142	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	7.87e-05	0.00137	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	7.67e-05	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	7.64e-05	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NCOR1—polycystic ovary syndrome	7.57e-05	0.00132	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—NR3C1—polycystic ovary syndrome	7.55e-05	0.00765	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	7.29e-05	0.00127	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP19A1—polycystic ovary syndrome	7.18e-05	0.00727	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—NR3C1—polycystic ovary syndrome	7e-05	0.00122	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP19A1—polycystic ovary syndrome	6.94e-05	0.00703	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	6.75e-05	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	6.73e-05	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	6.69e-05	0.00116	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.52e-05	0.00113	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	6.33e-05	0.0011	CbGpPWpGaD
Fludrocortisone—Progesterone—NR3C1—polycystic ovary syndrome	6.15e-05	0.00623	CrCbGaD
Fludrocortisone—AR—Gene Expression—YAP1—polycystic ovary syndrome	5.92e-05	0.00103	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	5.82e-05	0.00101	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NR3C1—polycystic ovary syndrome	5.62e-05	0.0057	CrCbGaD
Fludrocortisone—Progesterone—CYP1A1—polycystic ovary syndrome	5.58e-05	0.00566	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	5.53e-05	0.000963	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—polycystic ovary syndrome	5.42e-05	0.000944	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.3e-05	0.000923	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP1A1—polycystic ovary syndrome	5.28e-05	0.00535	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	5.23e-05	0.00091	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	5.22e-05	0.000908	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PGR—polycystic ovary syndrome	5.17e-05	0.000899	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP1A1—polycystic ovary syndrome	5.11e-05	0.00517	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—SERPINE1—polycystic ovary syndrome	4.89e-05	0.00085	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.71e-05	0.000819	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	4.65e-05	0.00081	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	4.49e-05	0.000781	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	4.02e-05	0.0007	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.97e-05	0.00069	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	3.96e-05	0.000689	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	3.92e-05	0.000682	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.57e-05	0.000622	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NCOR1—polycystic ovary syndrome	3.51e-05	0.000611	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR3C1—polycystic ovary syndrome	3.25e-05	0.000565	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AR—polycystic ovary syndrome	3.05e-05	0.00053	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	2.66e-05	0.000464	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—polycystic ovary syndrome	2.52e-05	0.000438	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	2.27e-05	0.000395	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	1.91e-05	0.000332	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.72e-05	0.000299	CbGpPWpGaD
